EMEA-000878-PIP02-11
Key facts
| Invented name |
BindRen
|
| Active substance |
colestilan
|
| Therapeutic area |
Uro-nephrology
|
| Decision number |
P/207/2011
|
| PIP number |
EMEA-000878-PIP02-11
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Treatment of hyperphosphataemia
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Mitsubishi Pharma Europe Ltd
|
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|